Effectiveness of needle/syringe programmes and opiate substitution therapy in preventing HCV transmission among people who inject drugs

Cochrane Database of Systematic Reviews

Volumn 2016, Issue 1, 2016, Pages

  Platt, Lucy ^a   Reed, Jennifer ^b   Minozzi, Silvia ^c   Vickerman, Peter ^d   Hagan, Holly ^b   French, Clare ^d   Jordan, Ashly ^b   Degenhardt, Louisa ^e   Hope, Vivian ^f   Hutchinson, Sharon ^g   Maher, Lisa ^h   Palmateer, Norah ^g   Taylor, Avril ⁱ   Hickman, Matthew ^d  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b NEW YORK UNIVERSITY   (United States)

^c DEPARTMENT OF EPIDEMIOLOGY   (Italy)

^d UNIVERSITY OF BRISTOL   (United Kingdom)

^e UNIVERSITY OF NEW SOUTH WALES   (Australia)

^f PUBLIC HEALTH ENGLAND   (United Kingdom)

^g HEALTH PROTECTION SCOTLAND   (United Kingdom)

^h UNIVERSITY OF NEW SOUTH WALES   (Australia)

ⁱ UNIVERSITY OF THE WEST OF SCOTLAND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BUPRENORPHINE; METHADONE;

CINAHL; CLINICAL ASSESSMENT; CLINICAL EFFECTIVENESS; COCHRANE LIBRARY; DRUG EXPOSURE; EMBASE; HEALTH PROGRAM; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INCIDENCE; INFECTION PREVENTION; MEDLINE; META ANALYSIS (TOPIC); MISCELLANEOUS NAMED GROUPS; MORBIDITY; NEEDLE SYRINGE PROGRAM; OPIATE SUBSTITUTION TREATMENT; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PEOPLE WHO INJECT DRUG; PRIORITY JOURNAL; PSYCINFO; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYRINGE NEEDLE; SYSTEMATIC REVIEW; THERAPY EFFECT; TREATMENT DURATION; TREATMENT INTERRUPTION; VIRUS TRANSMISSION;

EID: 84969523077     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD012021     Document Type: Review

References (30)

1. Amato L, Davoli M, Minozzi S, Ferroni E, Ali R, Ferri M. Methadone at tapered doses for the management of opioid withdrawal. Cochrane Database of Systematic Reviews 2013, Issue 2. [DOI: 10.1002/14651858.CD003409.pub4]
2. Aspinall EJ, Nambiar D, Goldberg DJ, Hickman M, Weir A, Van Velzen E, et al. Are needle and syringe programmes associated with a reduction in HIV transmission among people who inject drugs: a systematic review and meta-analysis. International Journal of Epidemiology 2014;43(1):235-48.
3. Committee on the Prevention of HIV infection among Injecting Drug Users in High-Risk Countries. Preventing HIV infection among injecting drug users in high-risk countries: an assessment of the evidence. Washington, DC, : Institute of Medicine, 2007.
4. Degenhardt L, Mathers B, Vickerman P, Rhodes T, Latkin C, Hickman M. Prevention of HIV infection for people who inject drugs: why individual, structural, and combination approaches are needed. Lancet 2010;376(9737):285-301.
5. Faggiano F, Vigna-Taglianti F, Versino E, Lemma P. Methadone maintenance at different dosages for opioid dependence. Cochrane Database of Systematic Reviews 2003, Issue 3. [DOI: 10.1002/14651858.CD002208]
6. Gibson DR, Flynn NM, Perales D. Effectiveness of syringe exchange programs in reducing HIV risk behavior and HIV seroconversion among injecting drug users. AIDS 2001;15(11):1329-41.
7. Gower E, Estes C, Blach S, Razavi-Shearer K, Razavi H. Global epidemiology and genotype distribution of the hepatitis C virus infection. Journal of Hepatology 2014;61(1 Suppl):S45-57.
8. Gowing L, Farrell MF, Bornemann R, Sullivan LE, Ali R. Oral substitution treatment of injecting opioid users for prevention of HIV infection. Cochrane Database of Systematic Reviews 2011, Issue 8. [DOI: 10.1002/14651858.CD004145.pub4]
9. The GRADE working group. Grading quality of evidence and strength of recommendations. BMJ 2004;328:1490-4.
10. Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 2008;336(7650):924-6.
11. Guyatt G, Oxman AD, Akl EA, Kunz R, Vist G, Brozek J, et al. GRADE guidelines 1. Introduction-GRADE evidence profiles and summary of findings tables. Journal of Clinical Epidemiology 2011;64:383-94.
12. Hagan H, Pouget ER, Des Jarlais DC. A systematic review and meta-analysis of interventions to prevent hepatitis C virus infection in people who inject drugs. Journal of Infectious Diseases 2011;204(1):74-83.
13. Higgins JPT, Green S. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration. Available from www.cochrane-handbook.org, 2011.
14. Jones L, Pickering L, Sumnall H, McVeigh J, Bellis MA. A Review of the Effectiveness and Cost-effectiveness of Needle and Syringe Programmes for Injecting Drug Users. Liverpool: Centre for Public Health, Liverpool John Moores University, 2011.
15. Kaplan EH, Heimer R. A model-based estimate of HIV infectivity via needle sharing. Journal of Acquired Immune Deficiency Syndromes 1992;5(11):1116-8.
16. MacArthur GJ, Minozzi S, Martin N, Vickerman P, Deren S, Bruneau J, et al. Opiate substitution treatment and HIV transmission in people who inject drugs: systematic review and meta-analysis. BMJ 2012;345:e5945.
17. Mathers BM, Degenhardt L, Ali H, Wiessing L, Hickman M, Mattick RP, et al. HIV prevention, treatment, and care services for people who inject drugs: a systematic review of global, regional, and national coverage. Lancet 2010;375(9719):1014-28.
18. Mohd Hanafiah K, Groeger J, Flaxman AD, Wiersma ST. Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence. Hepatology 2013;57(4):1333-42.
19. Palmateer N, Kimber J, Hickman M, Hutchinson S, Rhodes T, Goldberg D. Evidence for the effectiveness of sterile injecting equipment provision in preventing hepatitis C and human immunodeficiency virus transmission among injecting drug users: a review of reviews. Addiction 2010;105(5):844-59.
20. Perz JF, Armstrong GL, Farrington LA, Hutin YJ, Bell BP. The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. Journal of Hepatology 2006;45(4):529-38.
21. Platt L, Easterbrook P, Gower E, McDonald B, Sabin K, McGowan C, et al. Epidemiology of HIV and HCV co-infection: a systematic review. Lancet Infectious Diseases under review 2015.
22. Pouget ER, Hagan H, Des Jarlais DC. Meta-analysis of hepatitis C seroconversion in relation to shared syringes and drug preparation equipment. Addiction 2012;107(6):1057-65.
23. Schünemann HJ, Jaeschke R, Cook D, Bria W, El-Solh A, Ernst A, et al. An official ATS statement: grading the quality of evidence and strength of recommendations in ATS guidelines and recommendations. American Journal of Respiratory and Critical Care Medicine 2006;174:605-14.
24. Sterne J, Higgins J, Reeves B. Extending the risk of bias tool to allow for assessment of non-randomised studies, clust-randomised trials and cross-over trials:a Cochrane methods innovation fund project (Workshop), 21st Cochrane Colloquium Abstract Book. The Cochrane Collaboration, 2013.
25. Strathdee SA, Hallett TB, Bobrova N, Rhodes T, Booth R, Abdool R, et al. HIV and risk environment for injecting drug users: the past, present, and future. Lancet 2010;376(9737):268-84.
26. Tilson H, Aramrattana A, Bozzette SA. Preventing HIV Infection among Injecting Drug Users in High-risk Countries: An Assessment of the Evidence. Washington, DC: Institute of Medicine, 2007.
27. Turner KM, Hutchinson S, Vickerman P, Hope V, Craine N, Palmateer N, et al. The impact of needle and syringe provision and opiate substitution therapy on the incidence of hepatitis C virus in injecting drug users: pooling of UK evidence. Addiction 2011;106(11):1978-88.
28. UNAIDS Global Statistics. Fact Sheet. UNAIDS, 2014.
29. Van Den Berg C, Smit C, Van Brussel G, Coutinho R, Prins M. Full participation in harm reduction programmes is associated with decreased risk for human immunodeficiency virus and hepatitis C virus: evidence from the Amsterdam Cohort Studies among drug users. Addiction 2007;102(9):1452-62.
30. Wodak A, Cooney A. Effectiveness of sterile needle and syringe programming in reducing HIV/AIDS among injecting drug users. Evidence for Action Technical Papers. Geneva: World Health Organisation, 2004.